tetano
Editor, Senior Moderator
BMC Infect Dis
. 2023 Sep 21;23(1):622.
doi: 10.1186/s12879-023-08291-z. Reconstructing the cytokine view for the multi-view prediction of COVID-19 mortality
Yueying Wang[SUP] 1 2 3 4 [/SUP], Zhao Wang[SUP] 5 [/SUP], Yaqing Liu[SUP] 1 [/SUP], Qiong Yu[SUP] 4 [/SUP], Yujia Liu[SUP] 5 [/SUP], Changfan Luo[SUP] 5 [/SUP], Siyang Wang[SUP] 5 [/SUP], Hongmei Liu[SUP] 2 3 6 [/SUP], Mingyou Liu[SUP] 2 [/SUP], Gongyou Zhang[SUP] 2 [/SUP], Yusi Fan[SUP] 5 [/SUP], Kewei Li[SUP] 1 2 [/SUP], Lan Huang[SUP] 1 2 [/SUP], Meiyu Duan[SUP] 7 8 [/SUP], Fengfeng Zhou[SUP] 9 10 11 [/SUP]
Affiliations
Background: Coronavirus disease 2019 (COVID-19) is a rapidly developing and sometimes lethal pulmonary disease. Accurately predicting COVID-19 mortality will facilitate optimal patient treatment and medical resource deployment, but the clinical practice still needs to address it. Both complete blood counts and cytokine levels were observed to be modified by COVID-19 infection. This study aimed to use inexpensive and easily accessible complete blood counts to build an accurate COVID-19 mortality prediction model. The cytokine fluctuations reflect the inflammatory storm induced by COVID-19, but their levels are not as commonly accessible as complete blood counts. Therefore, this study explored the possibility of predicting cytokine levels based on complete blood counts.
Methods: We used complete blood counts to predict cytokine levels. The predictive model includes an autoencoder, principal component analysis, and linear regression models. We used classifiers such as support vector machine and feature selection models such as adaptive boost to predict the mortality of COVID-19 patients.
Results: Complete blood counts and original cytokine levels reached the COVID-19 mortality classification area under the curve (AUC) values of 0.9678 and 0.9111, respectively, and the cytokine levels predicted by the feature set alone reached the classification AUC value of 0.9844. The predicted cytokine levels were more significantly associated with COVID-19 mortality than the original values.
Conclusions: Integrating the predicted cytokine levels and complete blood counts improved a COVID-19 mortality prediction model using complete blood counts only. Both the cytokine level prediction models and the COVID-19 mortality prediction models are publicly available at http://www.healthinformaticslab.org/supp/resources.php .
Keywords: COVID-19; Complete blood counts; Cytokine prediction; Model-adjusted cytokine; Mortality prediction.
. 2023 Sep 21;23(1):622.
doi: 10.1186/s12879-023-08291-z. Reconstructing the cytokine view for the multi-view prediction of COVID-19 mortality
Yueying Wang[SUP] 1 2 3 4 [/SUP], Zhao Wang[SUP] 5 [/SUP], Yaqing Liu[SUP] 1 [/SUP], Qiong Yu[SUP] 4 [/SUP], Yujia Liu[SUP] 5 [/SUP], Changfan Luo[SUP] 5 [/SUP], Siyang Wang[SUP] 5 [/SUP], Hongmei Liu[SUP] 2 3 6 [/SUP], Mingyou Liu[SUP] 2 [/SUP], Gongyou Zhang[SUP] 2 [/SUP], Yusi Fan[SUP] 5 [/SUP], Kewei Li[SUP] 1 2 [/SUP], Lan Huang[SUP] 1 2 [/SUP], Meiyu Duan[SUP] 7 8 [/SUP], Fengfeng Zhou[SUP] 9 10 11 [/SUP]
Affiliations
- PMID: 37735372
- DOI: 10.1186/s12879-023-08291-z
Background: Coronavirus disease 2019 (COVID-19) is a rapidly developing and sometimes lethal pulmonary disease. Accurately predicting COVID-19 mortality will facilitate optimal patient treatment and medical resource deployment, but the clinical practice still needs to address it. Both complete blood counts and cytokine levels were observed to be modified by COVID-19 infection. This study aimed to use inexpensive and easily accessible complete blood counts to build an accurate COVID-19 mortality prediction model. The cytokine fluctuations reflect the inflammatory storm induced by COVID-19, but their levels are not as commonly accessible as complete blood counts. Therefore, this study explored the possibility of predicting cytokine levels based on complete blood counts.
Methods: We used complete blood counts to predict cytokine levels. The predictive model includes an autoencoder, principal component analysis, and linear regression models. We used classifiers such as support vector machine and feature selection models such as adaptive boost to predict the mortality of COVID-19 patients.
Results: Complete blood counts and original cytokine levels reached the COVID-19 mortality classification area under the curve (AUC) values of 0.9678 and 0.9111, respectively, and the cytokine levels predicted by the feature set alone reached the classification AUC value of 0.9844. The predicted cytokine levels were more significantly associated with COVID-19 mortality than the original values.
Conclusions: Integrating the predicted cytokine levels and complete blood counts improved a COVID-19 mortality prediction model using complete blood counts only. Both the cytokine level prediction models and the COVID-19 mortality prediction models are publicly available at http://www.healthinformaticslab.org/supp/resources.php .
Keywords: COVID-19; Complete blood counts; Cytokine prediction; Model-adjusted cytokine; Mortality prediction.